Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 5/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.52 |
| ▸ | NMUR2 | Q9GZQ4 | 5/20 | 0.50 |
| ▸ | NMUR1 | Q9HB89 | 5/20 | 0.50 |
| ▸ | NPFFR1 | Q9GZQ6 | 2/20 | 0.50 |
| ▸ | NPFFR2 | Q9Y5X5 | 2/20 | 0.50 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.49 |
| ▸ | NPY4R | P50391 | 3/20 | 0.48 |
| ▸ | NPY1R | P25929 | 2/20 | 0.48 |
| ▸ | NPY2R | P49146 | 2/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31679343 | 0.97 | OPRM1 (0.54) | OPRM1OPRD1NPFFR1NPFFR2EPHA2 | |
| SCHEMBL31679316 | 0.94 | OPRM1 (0.53) | OPRM1OPRD1NMUR2NMUR1NPFFR1 | |
| SCHEMBL31679413 | 0.94 | OPRM1 (0.53) | OPRM1OPRD1NPFFR1NPFFR2EPHA2 | |
| SCHEMBL31679457 | 0.93 | OPRM1 (0.53) | OPRM1OPRD1NMUR2NMUR1NPFFR1 | |
| SCHEMBL31679365 | 0.93 | OPRM1 (0.51) | OPRM1OPRD1NMUR2NMUR1NPFFR1 | |
| SCHEMBL31679446 | 0.93 | OPRD1 (0.48) | OPRM1OPRD1NMUR2NMUR1NPFFR1 | |
| SCHEMBL31679485 | 0.92 | OPRM1 (0.49) | OPRM1OPRD1NMUR2NMUR1NPFFR1 | |
| SCHEMBL31679347 | 0.91 | OPRM1 (0.55) | OPRM1OPRD1NMUR2NMUR1NPFFR1 | |
| SCHEMBL31679402 | 0.90 | OPRM1 (0.53) | OPRM1OPRD1NMUR2NMUR1NPFFR1 | |
| SCHEMBL31679339 | 0.90 | OPRM1 (0.47) | OPRM1OPRD1NMUR2NMUR1NPFFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4610269-A1 | UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE | 3B Pharmaceuticals GmbH (DE) | 2025-09-03 | — | — | EP | claimed |
| EP-4610269-A1 | UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE | 3B Pharmaceuticals GmbH (DE) | 2025-09-03 | — | — | EP | disclosed |